FDA approves pembrolizumab with chemotherapy for biliary tract cancer
On October 31, 2023, the Food and Drug Administration approved pembrolizumab to be used with gemcitabine…
Browsing: FDA Approvals
FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation
On October 11, 2023, the Food and Drug Administration approved encorafenib with binimetinib for adult patients with…
Tumour-destroying soundwaves approved for liver cancer treatment by FDA
The United States Food and Drug Administration has approved the use of sound waves to…
Uterine cancer drug gets fast-track approval
A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug…
Blood cancer therapy granted accelerated FDA approval
The US Food and Drug Administration (FDA) has given the green light to Elrexfio™ (elranatamab-bcmm),…
FDA approves melphalan as a liver-directed treatment for uveal melanoma
On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic…
FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions
On August 9, 2023, the Food and Drug Administration granted regular approval to pralsetinib for adult…
FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer
The Food and Drug Administration approved dostarlimab-gxly with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for…
FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer
On August 2, 2023, the Food and Drug Administration approved trifluridine and tipiracil, for metastatic…
FDA approves quizartinib for newly diagnosed acute myeloid leukaemia
On July 20, 2023, the Food and Drug Administration approved quizartinib with standard cytarabine and…